-(1)-(1)-1.jpg){kind=logo}
University of Maryland, Baltimore (UMB) will host the third International Conference of the Society for Interdisciplinary Placebo Studies (SIPS), “Harnessing Placebo Mechanisms for Optimal Pain Management and Treatment of Alcohol and Other Drug Use Disorders," virtually, May 26-28. The cost to attend is $15 for UMB affiliated faculty, staff, and students.
Expert faculty from UMB's Schools of Medicine, Nursing, and Pharmacy have collaborated with SIPS to design an interdisciplinary, international scientific conference to advance the science of placebo research and mind-body mechanisms and to apply this knowledge to alcohol use and pain disorders.
The conference will provide a collaborative platform to present and share innovative research findings and theoretical ideas on placebo research to an international audience of researchers; promote training and education of trainees, academic junior researchers, health care professionals, agencies, stakeholders, and the public; and advocate for the participation of minorities and women while expanding U.S. research in the global network of placebo research.
The program will include:
- Seven plenary sessions
- Three special sessions on COVID-19, placebo methodology, and virtual reality
- Over 20 workshops
- Peer-reviewed short oral presentations
- Peer-reviewed poster sessions
- Networking forums
Continuing education (CE) credit will be available for physicians, nurses, and pharmacists.
Funding available, please contact the 2021 SIPS Planning Committee if you need financial assistance in order to participate.
Special Session 2 sponsored by the Samueli Foundation
Keynote: What is Good Evidence? The Placebo Effect and Research Quality
Vinay Prasad, MD, MPH
Associate Professor
Department of Epidemiology and Biostatistics, University of California San Francisco
Prasad is a practicing hematologist-oncologist and associate professor in the Department of Epidemiology and Biostatistics at the University of California San Francisco. He studies cancer drugs, health policy, clinical trials, and better decision-making. He is author of over 250 academic articles, and the books "Ending Medical Reversal" (2015), and "Malignant" (2020). He hosts the oncology podcast Plenary Session, and runs a YouTube Channel VinayPrasadMDMPH. He tweets @VPrasadMDMPH.
Panelists:
- David Goldman, MD, PhD, clinical director, NIAAA
- Wayne Jonas, MD, executive director, Samueli Integrated Health Programs
- C. Daniel Mullins, PhD, director, PATIENTS-Oriented Center, University of Maryland School of Pharmacy
- Moderator: Luana Colloca, MD, PhD, associate professor, University of Maryland School of Nursing; director, CTSA TL1 Pre- and Postdoctoral Training Program, University of Maryland School of Medicine